Table 1.
Patient characteristics at baseline.
| Asian subgroup (n = 51) | International cohort (n = 456) (10) | |
|---|---|---|
| Age (years), mean (range) | 57.1 (47–68) | 56.7 (18–88) |
| Sex (male %), (M:F) | 34 (66.7%), (2:1) | 266 (58.3%), (3:2) |
| Time since onset of stroke (months), mean ± SD | 43.9 ± 66.1 | 61.4 ± 69.1 |
| Time since onset of spasticity (months), mean ± SD | 27.9 (25.0) | 48.2 (49.9) |
| First administration of BoNT-A in upper limb | 28 (54.9%) | 149 (32.7%) |
| Etiology of cerebrovascular accident (CVA) | ||
| Infarct | 29 (56.9%) | 320 (70.2%) |
| Hemorrhage | 22 (43.1%) | 139 (30.5%) |
| Infarct and Hemorrhage | 0 | 3 (0.7%) |
| Presence of mixed contractures | 13 (25.5%) | 116 (25.4%) |
| Presence of severe weakness | 17 (33.3%) | 264 (57.9%) |
| Impaired sensation, n (%) | 22 (43.2%) | 228 (50.0%) |
| Impaired communication, n (%) | 8 (15.7%) | 159 (34.9%) |
| Impaired cortical function, n (%) | 3 (5.9%) | 60 (13.2%) |
| Emotional/ behavioral dysfunction, n (%) | 8 (15.7%) | 149 (32.7%) |
| Presence of pain | 2 (3.9%) | 78 (17.1%) |
| Presence of fatigue | 0 | 48 (10.5%) |